JP2011195522A - Solubilizing agent comprising alkylene oxide derivative and solubilizing composition including the same - Google Patents
Solubilizing agent comprising alkylene oxide derivative and solubilizing composition including the same Download PDFInfo
- Publication number
- JP2011195522A JP2011195522A JP2010065488A JP2010065488A JP2011195522A JP 2011195522 A JP2011195522 A JP 2011195522A JP 2010065488 A JP2010065488 A JP 2010065488A JP 2010065488 A JP2010065488 A JP 2010065488A JP 2011195522 A JP2011195522 A JP 2011195522A
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkylene oxide
- solubilizing
- oxide derivative
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000002947 alkylene group Chemical group 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 239000002904 solvent Substances 0.000 title claims abstract description 17
- 230000003381 solubilizing effect Effects 0.000 title abstract description 8
- 125000005702 oxyalkylene group Chemical group 0.000 claims abstract description 23
- 125000006353 oxyethylene group Chemical group 0.000 claims abstract description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 19
- 238000005063 solubilization Methods 0.000 abstract description 8
- 230000007928 solubilization Effects 0.000 abstract description 8
- 239000004615 ingredient Substances 0.000 abstract description 4
- -1 polyoxyethylene Polymers 0.000 description 27
- 150000001875 compounds Chemical class 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 239000003205 fragrance Substances 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000006210 lotion Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- 238000002834 transmittance Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical group CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- NJWSNNWLBMSXQR-UHFFFAOYSA-N 2-hexyloxirane Chemical compound CCCCCCC1CO1 NJWSNNWLBMSXQR-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SLIVDYMORZGPLW-UHFFFAOYSA-N 4-methyl-n-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-([1,2,4]triazolo[4,3-a]pyridin-3-yl)ethynyl]benzamide Chemical compound C1CN(C)CCN1CC(C(=C1)C(F)(F)F)=CC=C1NC(=O)C1=CC=C(C)C(C#CC=2N3C=CC=CC3=NN=2)=C1 SLIVDYMORZGPLW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- PFZIYVBTRVUHQV-UHFFFAOYSA-N oxacyclododecane Chemical compound C1CCCCCOCCCCC1 PFZIYVBTRVUHQV-UHFFFAOYSA-N 0.000 description 1
- INSIURULIZUZHA-UHFFFAOYSA-N oxacyclotridecane Chemical compound C1CCCCCCOCCCCC1 INSIURULIZUZHA-UHFFFAOYSA-N 0.000 description 1
- WTQUVYBGJUBJSW-UHFFFAOYSA-N oxacycloundecane Chemical compound C1CCCCCOCCCC1 WTQUVYBGJUBJSW-UHFFFAOYSA-N 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- FWICBZQTZDXXOL-UHFFFAOYSA-N oxecane Chemical compound C1CCCCOCCCC1 FWICBZQTZDXXOL-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 239000002446 δ-tocopherol Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本発明は、アルキレンオキシド誘導体からなる可溶化剤、及びこれを配合してなる可溶化組成物に関する。 The present invention relates to a solubilizer comprising an alkylene oxide derivative and a solubilized composition comprising the solubilizer.
近年アンチエイジングや美白を望む声が高まっており、酢酸トコフェロールやコエンザイムQ10などのような抗酸化作用や美白作用を有する薬効成分が化粧料に配合されることが多くなっている。これら成分の多くは非極性の油性成分であり、水系の化粧品に配合すると白濁するため、商品価値を損ねる。これら課題を解決するために、各種界面活性剤によりこの油性成分を可溶化させるのが一般的である。 In recent years, there is an increasing demand for anti-aging and whitening, and medicinal ingredients having an antioxidative action and a whitening action such as tocopherol acetate and coenzyme Q10 are often added to cosmetics. Many of these components are non-polar oily components, and when blended with water-based cosmetics, they become cloudy, thereby impairing the commercial value. In order to solve these problems, it is common to solubilize this oil component with various surfactants.
各種界面活性剤としては、CMCが低いため、より低濃度で可溶化できる非イオン性界面活性剤が汎用されており、非イオン性界面活性剤の中でも、アルキレンオキシド誘導体は、付加モル数によって、親水―親油バランスを自在に調整することが可能であり、非常に有用である。 As various surfactants, nonionic surfactants that can be solubilized at a lower concentration are widely used because CMC is low. Among nonionic surfactants, alkylene oxide derivatives are added depending on the number of added moles. It is possible to adjust the hydrophilic-lipophilic balance freely, which is very useful.
可溶化力が高いアルキレンオキシド誘導体の界面活性剤として、ポリオキシエチレン硬化ヒマシ油(特許文献1)や、モノオレイン酸ポリオキシエチレンソルビタンなどのソルビタンエステル誘導体(特許文献2)、これら2種類を組み合わせた配合物(特許文献3)といったものが知られている。しかし、上記界面活性剤はべたつきを感じるといった課題があった。 As surfactants of alkylene oxide derivatives with high solubilizing power, polyoxyethylene hydrogenated castor oil (Patent Document 1), sorbitan ester derivatives such as polyoxyethylene sorbitan monooleate (Patent Document 2), and a combination of these two Such a compound (Patent Document 3) is known. However, the surfactant has a problem that it feels sticky.
また、エーテル型非イオン性界面活性剤として、炭化水素鎖を親油基としたアルキルエーテル型アルキレンオキシドやポリプロピレンオキシドやポリブチレンオキシドを親油基としたプルロニック型アルキレンオキシド誘導体(特許文献4)がある。しかし、これら界面活性剤で非極性の油性成分を可溶化するには充分な効果を発揮することができず、可溶化させるために高配合すると使用感が低下する。そのため、これら課題を満たす化粧料用界面活性剤の開発が求められてきた。 Further, as ether type nonionic surfactants, alkyl ether type alkylene oxides having a hydrocarbon chain as a lipophilic group, pluronic type alkylene oxide derivatives having a lipophilic group as a polypropylene oxide or polybutylene oxide (Patent Document 4) are available. is there. However, these surfactants cannot exhibit a sufficient effect to solubilize non-polar oily components, and if they are blended at a high level for solubilization, the feeling of use decreases. Therefore, development of a surfactant for cosmetics that satisfies these problems has been demanded.
本発明が解決しようとする課題は、香料、油溶性薬剤などといった難水溶性の油性成分に対し優れた可溶化力を有する上、使用感が良好で、使用後のべたつきが少ない可溶化剤を提供することである。 The problem to be solved by the present invention is to provide a solubilizing agent that has excellent solubilizing power for poorly water-soluble oily components such as fragrances and oil-soluble drugs, and has a good feeling of use and less stickiness after use. Is to provide.
本発明者らは、上記課題につき鋭意研究の結果、ある種のアルキレンオキシド誘導体が、優れた可溶化力と使用感を併せ持つことを見出し、本発明を完成した。
すなわち、本発明は以下に示されるものである。
(1) 式(I)で示されるアルキレンオキシド誘導体からなる可溶化剤。
HO−(EO)a−(AO)n−(EO)b−H (I)
(式中、EOはオキシエチレン基、AOは炭素数8〜12の1種又は2種以上のオキシアルキレン基であり、AOが2種以上の場合は、ブロック状に付加していてもランダム状に付加していてもよく、AOとEOの付加形態はブロック状である。aとbは前記オキシエチレン基、nはオキシアルキレン基の平均付加モル数であり、10≦a+b≦300、2≦n≦50、及び0.75≦(a+b)/(a+b+n)≦0.99の関係を有する。)
(2)AOが炭素数8〜10のオキシアルキレン基である、上記可溶化剤。
(3)(A)請求項1又は2記載のアルキレンオキシド誘導体を0.01〜50質量%
(B)油性成分を0.001〜10質量%
含有し、成分(A)及び(B)の質量割合が(A)/(B)=0.1〜20である、可溶化組成物。
As a result of intensive studies on the above problems, the present inventors have found that certain alkylene oxide derivatives have both excellent solubilization power and feeling of use and have completed the present invention.
That is, the present invention is as follows.
(1) A solubilizer comprising an alkylene oxide derivative represented by the formula (I).
HO- (EO) a- (AO) n- (EO) b-H (I)
(In the formula, EO is an oxyethylene group, AO is one or two or more oxyalkylene groups having 8 to 12 carbon atoms, and when AO is two or more, it may be randomly added even if added in a block form. The addition form of AO and EO is in the form of a block, a and b are the oxyethylene groups, n is the average number of moles of oxyalkylene groups, and 10 ≦ a + b ≦ 300, 2 ≦ (n ≦ 50 and 0.75 ≦ (a + b) / (a + b + n) ≦ 0.99)
(2) The above-mentioned solubilizer, wherein AO is an oxyalkylene group having 8 to 10 carbon atoms.
(3) (A) 0.01 to 50% by mass of the alkylene oxide derivative according to claim 1 or 2
(B) 0.001 to 10% by mass of oil component
The solubilized composition which contains and the mass ratio of component (A) and (B) is (A) / (B) = 0.1-20.
本発明のアルキレンオキシド誘導体からなる可溶化剤は、水系製剤に対する油溶性の美容成分や医薬成分、着色剤や香料、あるいは一般の油脂類の溶解性を顕著に向上させることができる。しかも、当該可溶化剤を使用して調製した油性成分を含有する可溶化組成物は、肌に対するなじみ性がよく、べたつきも少ないなど、使用感が顕著に優れる。したがって、本発明の可溶化組成物は、肌に直接適用する、化粧料、あるいは医薬部外品や外用医薬品など、皮膚外用剤として、とくに有用である。
The solubilizer comprising the alkylene oxide derivative of the present invention can remarkably improve the solubility of oil-soluble cosmetic and pharmaceutical ingredients, colorants and fragrances, or general fats and oils in aqueous preparations. In addition, the solubilized composition containing the oil component prepared using the solubilizer is remarkably excellent in usability, such as good conformability to the skin and little stickiness. Therefore, the solubilized composition of the present invention is particularly useful as an external preparation for skin, such as cosmetics, quasi-drugs and external medicines, which are directly applied to the skin.
以下、本発明の好適な実施形態について説明する。
式(I)で示されるアルキレンオキシド誘導体において、EOはオキシエチレン基である。a及びbはオキシエチレン基の平均付加モル数で、10≦a+b≦300、好ましくは20≦a+b≦250、より好ましくは30≦a+b≦200である。10より小さいと可溶化力が充分に発揮できない傾向にあり、200を超えると使用感に劣る傾向にある。
Hereinafter, preferred embodiments of the present invention will be described.
In the alkylene oxide derivative represented by the formula (I), EO is an oxyethylene group. a and b are the average addition mole number of an oxyethylene group, and are 10 <= a + b <= 300, Preferably it is 20 <= a + b <= 250, More preferably, it is 30 <= a + b <= 200. If it is less than 10, the solubilizing power tends not to be sufficiently exhibited, and if it exceeds 200, the feeling of use tends to be inferior.
AOは炭素数8〜12のオキシアルキレン基であり、好ましくは炭素数8〜10のオキシアルキレン基である。例えば炭素数8のオキシアルキレン基としてはオキシオクタメチレン基、オキシオクチレン基など、炭素数9のオキシアルキレン基としてはオキシノナメチレン基、オキシノニレン基など、炭素数10のオキシアルキレン基としてはオキシデカメチレン基、オキシデシレン基など、炭素数11のオキシアルキレン基としてはオキシウンデカメチレン基、オキシウンデシレン基など、炭素数12のオキシアルキレン基としてはオキシドデカメチレン基、オキシドデシレン基などが挙げられる。炭素数が7以下のオキシアルキレン基は可溶化力が充分に発揮できない傾向にあり、炭素数13以上となると使用感が劣る傾向にある。これらオキシアルキレン基は直鎖状もしくは分岐状のいずれであってもよい。分岐状のオキシアルキレン基において、炭素数8のオキシアルキレン基としては、オクチレンオキシド由来のオキシオクチレン基があり、例えば1,2−オキシオクチレン基など、炭素数9のオキシアルキレン基としては、ノニレンオキシド由来のオキシノニレン基があり、例えば1,2−オキシノニレン基など、炭素数10のオキシデシレン基としては、デシレンオキシド由来のオキシデシレン基があり、例えば1,2−オキシデシレン基など、炭素数11のオキシドデシレン基としては、ドデシレンオキシド由来のオキシドデシレン基があり、例えば1,2−オキシドデシレン基など、炭素数12のオキシデシレン基としては、ウンデシレンオキシド由来のオキシウンデシレン基があり、例えば1,2−オキシウンデシレン基などが挙げられる。 AO is an oxyalkylene group having 8 to 12 carbon atoms, preferably an oxyalkylene group having 8 to 10 carbon atoms. For example, oxyoctamethylene and oxyoctylene groups such as an oxyalkylene group having 8 carbon atoms, oxynonamethylene groups and oxynonylene groups such as an oxyalkylene group having 9 carbon atoms, and oxydecacene as an oxyalkylene group having 10 carbon atoms. Examples of the oxyalkylene group having 11 carbon atoms such as a methylene group and an oxydecylene group include an oxyundecamethylene group and oxyundecylene group, and examples of the oxyalkylene group having 12 carbon atoms include an oxide decamethylene group and an oxydecylene group. An oxyalkylene group having 7 or less carbon atoms tends not to have a sufficient solubilizing power, and when it has 13 or more carbon atoms, the feeling of use tends to be inferior. These oxyalkylene groups may be either linear or branched. In the branched oxyalkylene group, as the oxyalkylene group having 8 carbon atoms, there is an oxyoctylene group derived from octylene oxide. For example, as an oxyalkylene group having 9 carbon atoms such as 1,2-oxyoctylene group, There are oxynonylene groups derived from nonylene oxide, for example, oxydecylene groups having 10 carbon atoms such as 1,2-oxynonylene groups include oxydecylene groups derived from decylene oxide, such as 1,2-oxydecylene groups. As the 11 oxydecylene group, there is an oxydecylene group derived from dodecylene oxide. For example, as an oxydecylene group having 12 carbon atoms such as 1,2-oxide decylene group, an oxyundecylene group derived from undecylene oxide is used. Yes, for example 1,2-oxyundecylene group It is.
式(I)で示されるアルキレンオキシド誘導体の製造過程における、アルキレンオキシドの開裂反応は、α開裂、β開裂、又はその混合型のいずれであってもよい。例えば炭素数8のオクチレンオキシド由来の1,2−オクチレンオキシドの場合、下記一般式(II)で表されるオキシ−1−ヘキシルエチレン基、又は下記一般式(III)で表されるオキシ−2−ヘキシルエチレン基のいずれかとなる。 The cleavage reaction of the alkylene oxide in the production process of the alkylene oxide derivative represented by the formula (I) may be any of α-cleavage, β-cleavage, or a mixed type thereof. For example, in the case of 1,2-octylene oxide derived from octylene oxide having 8 carbon atoms, an oxy-1-hexylethylene group represented by the following general formula (II) or an oxy represented by the following general formula (III) It becomes either 2-hexylethylene group.
nはオキシアルキレン基の平均付加モル数で、2≦n≦50であり、好ましくは3≦n≦30である。 n is an average addition mole number of the oxyalkylene group, 2 ≦ n ≦ 50, preferably 3 ≦ n ≦ 30.
オキシエチレン基とオキシアルキレン基の平均付加モル数の合計(a+b+n)に対するオキシエチレン基の平均付加モル数(a+b)の割合は0.75≦(a+b)/(a+b+n)≦0.99である。0.75より小さい、又は0.99より大きいと満足のいく可溶化力が得られず好ましくない。 The ratio of the average added mole number (a + b) of the oxyethylene group to the sum (a + b + n) of the average added mole number of the oxyethylene group and the oxyalkylene group is 0.75 ≦ (a + b) / (a + b + n) ≦ 0.99. If it is smaller than 0.75 or larger than 0.99, a satisfactory solubilizing force cannot be obtained, which is not preferable.
オキシエチレン基とオキシアルキレン基の付加形態はブロック状であることが好ましく、配列順序はオキシエチレン基−オキシアルキレン基−オキシエチレン基の順である。オキシアルキレン基は炭素数8〜12の範囲であれば、1種類でもよく、2種類以上でもよく、2種類以上の場合の付加形態はブロック状でもランダム状でもよい。 The addition form of the oxyethylene group and the oxyalkylene group is preferably a block form, and the arrangement order is the order of oxyethylene group-oxyalkylene group-oxyethylene group. As long as the oxyalkylene group is in the range of 8 to 12 carbon atoms, one type may be used, two or more types may be used, and the addition form in the case of two or more types may be block or random.
本発明の可溶化組成物において用いる成分(A)のアルキレンオキシド誘導体は式(I)で示される構造であり、組成物全体に対する配合割合は0.01〜50質量%、好ましくは0.02〜30質量%、より好ましくは0.05〜10質量%である。 The alkylene oxide derivative of the component (A) used in the solubilized composition of the present invention has a structure represented by the formula (I), and the blending ratio with respect to the entire composition is 0.01 to 50% by mass, preferably 0.02 to 30% by mass, more preferably 0.05 to 10% by mass.
本発明の可溶化組成物において用いる成分(B)の油性成分は、化粧品、医薬部外品、外用医薬品に配合される油性物質であれば、揮発性、不揮発性のいずれでもよく、常温における形態として固体状、ペースト状、液体状のいずれであってもよい。例えば、ビタミンA、D、E、K等の油溶性ビタミン、動植物の抽出物、合成・半合成の油溶性薬剤や美容成分、各種油分、香料、などの非水溶性物質が挙げられる。油溶性ビタミン類としては、レチノール等のビタミンAや酢酸トコフェロール、αートコフェロール、δートコフェロールなどのビタミンE類、コレカルシフェロールなどのビタミンD類が、合成・半合成の油溶性薬剤としては、ユビキノン等が、油分としては、オリーブ油、アボガド油、ひまし油、サフラワー油、綿実油、カカオ脂、ヤシ油等の液状又は固体油脂類、ミリスチン酸イソプロピル、オクタン酸セチル、ステアリン酸等のエステル類、アルコールアルキルエーテル等のエーテル類、流動パラフィン、ワセリン、マイクロクリスタリンワックス等の炭化水素類、ミツロウ、ラノリン、カルバナウロウ等のロウ類、ジメチルポリシロキサン等のシリコーン系の油相成分、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸等の脂肪酸類、ラウリルアルコール、セタノール、ステアリルアルコール、オレイルアルコール等の高級アルコール類などが、香料としては天然香料、合成香料、調合香料、天然香料から単離された香料などが例示される。油性成分は、1種類又は2種類以上を配合することができる。 The oil component of the component (B) used in the solubilized composition of the present invention may be either volatile or non-volatile as long as it is an oily substance blended in cosmetics, quasi drugs, and external medicines. Any of solid, paste, and liquid may be used. Examples thereof include water-insoluble substances such as oil-soluble vitamins such as vitamins A, D, E, and K, animal and plant extracts, synthetic and semi-synthetic oil-soluble drugs and cosmetic ingredients, various oils, and fragrances. As oil-soluble vitamins, vitamin A such as retinol, vitamin E such as tocopherol acetate, α-tocopherol, and δ-tocopherol, and vitamin D such as cholecalciferol are synthetic and semi-synthetic oil-soluble drugs. Ubiquinone, etc. includes oils such as olive oil, avocado oil, castor oil, safflower oil, cottonseed oil, cocoa butter, coconut oil and other liquid or solid oils, esters such as isopropyl myristate, cetyl octanoate and stearic acid, alcohol Ethers such as alkyl ethers, hydrocarbons such as liquid paraffin, petrolatum, and microcrystalline wax, waxes such as beeswax, lanolin, and carbanau wax, silicone oil phase components such as dimethylpolysiloxane, lauric acid, myristic acid, palmitic Acid, stearic acid, etc. Higher alcohols such as fatty acids, lauryl alcohol, cetanol, stearyl alcohol, oleyl alcohol and the like, and examples of the fragrance include natural fragrances, synthetic fragrances, blended fragrances, and fragrances isolated from natural fragrances. One or more oily components can be blended.
本発明の可溶化組成物の全組成中に対する油性成分(B)の配合量は、0.001〜10質量%、好ましくは0.002〜5質量%、より好ましくは0.005〜3質量%である。 The blending amount of the oil component (B) in the total composition of the solubilized composition of the present invention is 0.001 to 10% by mass, preferably 0.002 to 5% by mass, more preferably 0.005 to 3% by mass. It is.
成分(A)と成分(B)の質量割合は、優れた可溶化安定性を得る観点から、(A)/(B)=0.1〜20程度がよく、好ましくは0.2〜15、より好ましくは0.5〜10である。 From the viewpoint of obtaining excellent solubilization stability, the mass ratio of the component (A) and the component (B) is preferably about (A) / (B) = 0.1 to 20, preferably 0.2 to 15, More preferably, it is 0.5-10.
本発明の可溶化組成物には、化粧品、医薬部外品、外用医薬品などに一般に配合される、上記成分以外の界面活性剤、エタノールなどの溶剤、カルボキシメチルセルロース、ヒドロキシプロピルメチルセルロース、アラビアガム、カラギーナン等の増粘安定剤、その他の油分、ポリエチレングリコール、グリセリン、プロピレングリコール、1,3−ブチレングリコール等の保湿剤、クエン酸、酢酸、酒石酸、乳酸等のpH調整剤、キレート剤、薬剤、紫外線吸収剤、紫外線散乱剤、フェノキシエタノール、パラオキシ安息香酸等の防腐剤、香料、顔料、染料などの他の成分を配合してもよい。それらの成分は、各1種類ずつ配合してもよく、2種類以上配合してもよい。 In the solubilized composition of the present invention, surfactants other than the above components, solvents such as ethanol, carboxymethylcellulose, hydroxypropylmethylcellulose, gum arabic, carrageenan, which are generally blended in cosmetics, quasi-drugs, external medicines, etc. Thickening stabilizers such as other oils, moisturizers such as polyethylene glycol, glycerin, propylene glycol, 1,3-butylene glycol, pH adjusters such as citric acid, acetic acid, tartaric acid, lactic acid, chelating agents, chemicals, ultraviolet rays You may mix | blend other components, such as preservatives, such as an absorber, a ultraviolet-ray scattering agent, phenoxyethanol, and a paraoxybenzoic acid, a fragrance | flavor, a pigment, and dye. These components may be blended one by one or two or more.
本発明の可溶化剤は、さまざまな油性物質をよく溶解し、しかも、当該可溶化剤によって可溶化した、油性物質を含有する組成物は、肌に対する感触が良好であることから、油性物質の配合ニーズとともに可溶化に関する技術的課題を有し、肌に対する良好な使用感をも求められる化粧料への配合に特に適する。同様に良好な使用感が望まれる、医薬外用剤への配合にも適する。したがって、本発明の可溶化組成物は、皮膚や毛髪用の化粧料、医薬部外品や外用の医薬品等として適する。
The solubilizing agent of the present invention dissolves various oily substances well, and the composition containing the oily substances solubilized by the solubilizing agent has a good feel to the skin. It has technical problems related to solubilization as well as blending needs, and is particularly suitable for blending into cosmetics that require a good feeling on the skin. Similarly, it is also suitable for blending into a pharmaceutical preparation for which good use feeling is desired. Therefore, the solubilized composition of the present invention is suitable as a cosmetic for skin and hair, a quasi-drug, a pharmaceutical for external use, and the like.
以下に実施例を挙げて本発明をさらに詳細に説明するが、本発明はこれに限定されるものではない。製造例1及び2として化合物1(表1)の例を示す。 Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited thereto. Examples of Compound 1 (Table 1) are shown as Production Examples 1 and 2.
製造例1(オキシオクチレン化反応)
1,2−オクタンジオール118gと三フッ化ホウ素ジエチルエーテル1.7gを5L容オートクレーブに仕込み、乾燥窒素で置換した後、撹拌しながら、1,2−オクチレンオキシド800gを滴下させ、3時間撹拌した。反応物を取り出し、水酸化カリウムで中和しpH6〜7とし、含有する水分を100℃で1時間処理することで除去し、さらに生成した塩を除去するためにろ過を行い、ポリオキシオクチレン902gを得た。水酸基価は123.9KOHmg/gであった。
Production Example 1 (oxyoctylene formation reaction)
After charging 118 g of 1,2-octanediol and 1.7 g of boron trifluoride diethyl ether in a 5 L autoclave and replacing with dry nitrogen, 800 g of 1,2-octylene oxide was added dropwise with stirring and stirring for 3 hours. did. The reaction product was taken out, neutralized with potassium hydroxide to pH 6-7, and the contained water was removed by treating at 100 ° C. for 1 hour, followed by filtration to remove the formed salt, and polyoxyoctylene. 902 g was obtained. The hydroxyl value was 123.9 KOHmg / g.
製造例2(オキシエチレン化反応)
製造例1で得られたポリオキシオクチレン450gと水酸化カリウム1.5gを5L容オートクレーブに仕込み、乾燥窒素で置換した後、撹拌しながら140℃で水酸化カリウムを完全に溶解した。引き続き、140℃、0.2〜0.5MPa(ゲージ圧)にて、滴下装置よりエチレンオキシド300gを滴下し、2時間撹拌した。その後オートクレーブより反応物を取り出し、塩酸で中和してpH6〜7とし、含有する水分を100℃で1時間処理することで除去した。更に処理後精製した塩を除去するためにろ過を行い、化合物1を得た。水酸基価は48.6KOHmg/gであった。
Production Example 2 (oxyethylenation reaction)
After 450 g of polyoxyoctylene obtained in Production Example 1 and 1.5 g of potassium hydroxide were charged into a 5 L autoclave and replaced with dry nitrogen, potassium hydroxide was completely dissolved at 140 ° C. with stirring. Subsequently, 300 g of ethylene oxide was dropped from a dropping device at 140 ° C. and 0.2 to 0.5 MPa (gauge pressure), followed by stirring for 2 hours. Thereafter, the reaction product was taken out from the autoclave, neutralized with hydrochloric acid to pH 6-7, and the contained water was removed by treating at 100 ° C. for 1 hour. Further, filtration was performed to remove the purified salt after the treatment to obtain Compound 1. The hydroxyl value was 48.6 KOHmg / g.
本発明者らは、上記製造例に準じて、下記表1のアルキレンオキシド誘導体である化合物2〜9を合成した。 The present inventors synthesized compounds 2 to 9, which are alkylene oxide derivatives shown in Table 1 below, according to the above production examples.
表1の化合物1〜11について、表2のように配合して可溶化状態を確認した。 About the compounds 1-11 of Table 1, it mix | blended like Table 2 and the solubilization state was confirmed.
<可溶化状態確認>
系が可溶化状態であることは、以下の方法に従って確認した。すなわち、吸光度測定器;分光光度計(JASCO)V−530を用いて、25℃、600nmの波長を有する可視光の1cmセルの透過率%を測定し、透過率90%以上を良好とした。
◎:透過率95%以上
○:透過率90%以上95%未満
△:透過率80%以上90%未満
×:透過率50%以上80%未満
××:透過率50%未満
<組成物>
d−δ−トコフェロール 0.05質量%
可溶化剤 表2参照
エタノール 5.0質量%
水 残部
<Confirmation of solubilized state>
It was confirmed according to the following method that the system was in a solubilized state. That is, using a spectrophotometer (JASCO) V-530, the transmittance% of a 1 cm cell of visible light having a wavelength of 25 ° C. and 600 nm was measured, and a transmittance of 90% or more was determined to be good.
◎: Transmittance 95% or more ○: Transmittance 90% or more and less than 95% Δ: Transmittance 80% or more and less than 90% ×: Transmittance 50% or more and less than 80% XX: Transmittance less than 50% <Composition>
d-δ-tocopherol 0.05 mass%
Solubilizer See Table 2 Ethanol 5.0% by mass
Water balance
表2において、化合物5〜7及び9は、(A)/(B)=20としてもトコフェロールを可溶化することができず、化合物8は(A)/(B)=20とすると可溶化したが、(A)/(B)=10では良好な可溶化状態とならなかった。
化合物5はランダム付加であり、化合物6及び7は親水基と親油基の双方を有しないためであり、化合物9は親水基と親油基を有するが、親油基がオキシプロピレン基では不充分であった。また、化合物8も可溶化力が弱いため、良好な可溶化状態とするには、添加量を多くしなければいけない。それに対し、本発明品である化合物1〜4、化合物10及び11は(A)/(B)=10で良好な可溶化状態となった。
In Table 2, compounds 5-7 and 9 could not solubilize tocopherol even when (A) / (B) = 20, and compound 8 solubilized when (A) / (B) = 20 However, when (A) / (B) = 10, a good solubilized state was not obtained.
This is because compound 5 is a random addition, and compounds 6 and 7 do not have both a hydrophilic group and a lipophilic group, and compound 9 has a hydrophilic group and a lipophilic group, but the lipophilic group is not an oxypropylene group. It was enough. Moreover, since the compound 8 also has a weak solubilizing power, the amount added must be increased in order to obtain a good solubilized state. On the other hand, the compounds 1 to 4 and the compounds 10 and 11 which are the products of the present invention were in a good solubilized state at (A) / (B) = 10.
可溶化状態が良好な結果となった表1の化合物1〜4、8、10、11について、表3、4のように配合した化粧水を製造し、官能評価(製造時の感触及び、使用後のべたつき)及び安定性評価を行った。アルキレンオキシド誘導体とトコフェロールとの配合割合は、上記可溶化状態を確認した割合に従った。実施例の可溶化安定性はすべて良好となった。評価結果を表3、4に併せて示す。 A lotion formulated as shown in Tables 3 and 4 was prepared for the compounds 1 to 4, 8, 10, and 11 in Table 1 in which the solubilized state was good, and sensory evaluation (feel and use during production) Later stickiness) and stability evaluation. The blending ratio of the alkylene oxide derivative and tocopherol was in accordance with the ratio at which the solubilized state was confirmed. The solubilization stability of the examples was all good. The evaluation results are also shown in Tables 3 and 4.
<使用時の感触>
製造直後の化粧水について、使用時の感触は以下の方法に従って行った。すなわち、20名の専門女性パネラーにより、洗顔した後に化粧水を使用したときの感触について下記のように5段階で判定し、20名の平均値を求めて、平均値3.5以上を使用時の感触のよい化粧水であると判断した。
5:使用時に肌へのなじみが非常に良好で、とても軽い感触である。
4:使用時に肌へのなじみが良好で、軽い感触である。
3:使用時に肌へのなじみがやや良好で、やや軽い感触である。
2:使用時に肌へのなじみがやや良好で、若干重い感触である。
1:使用時に肌へのなじみが悪く、重い感触である。
<Feel when using>
About the lotion immediately after manufacture, the touch at the time of use was performed in accordance with the following method. That is, 20 professional female panelists judge the feel when using lotion after washing their face in five stages as follows, and find the average value of 20 people, when using an average value of 3.5 or more It was judged that the lotion had a good touch.
5: Familiarity with the skin is very good during use, and the feel is very light.
4: Familiarity to skin during use and light feel.
3: Familiarity to skin during use is slightly good and feels slightly light.
2: Familiarity to skin during use is slightly good, and feels slightly heavy.
1: The skin feels bad when used and has a heavy feel.
<使用後のべたつき>
調製直後の化粧水について、使用10分後のべたつきを以下の方法によって判定した。すなわち、20名の専門女性パネラーにより、洗顔した後に化粧水を使用した後、10分経ったときのべたつきについて下記のように5段階で判定し、20名の平均値を求めて、平均値3.5以上をべたつきのない化粧水であると判断した。
5:肌が全くべたつかないと感じる。
4:肌がべたつかないと感じる。
3:肌がややべたつくと感じる。
2:肌がべたつくと感じる。
1:肌がべたつくとはっきりと感じる。
<Stickiness after use>
About the lotion immediately after preparation, the stickiness 10 minutes after use was determined by the following method. That is, 20 professional female panelists use a lotion after washing their face, and after 10 minutes, the stickiness after 10 minutes is judged in 5 stages as follows, and the average value of 20 people is obtained. .5 or more were judged to be non-sticky lotions.
5: I feel that my skin is not sticky at all.
4: Feels that the skin is not sticky.
3: I feel that my skin is slightly sticky.
2: Feels that the skin is sticky.
1: It feels clear when the skin is sticky.
表3のように、実施例1〜4は官能評価すべてにおいて良好な結果が得られた。表4では、比較例1は可溶化させるために高配合したことにより感触が低下した。比較例2、3は使用時の感触が劣る、又はべたつきを感じられた。 As shown in Table 3, in Examples 1 to 4, good results were obtained in all sensory evaluations. In Table 4, the touch of Comparative Example 1 was lowered due to the high blending for solubilization. In Comparative Examples 2 and 3, the feeling during use was inferior or sticky.
Claims (3)
HO−(EO)a−(AO)n−(EO)b−H (I)
(式中、EOはオキシエチレン基、AOは炭素数8〜12の1種又は2種以上のオキシアルキレン基であり、AOが2種以上の場合は、ブロック状付加又はランダム状付加であってもよく、AOとEOの付加形態はブロック状である。a及びbは前記オキシエチレン基、nはオキシアルキレン基の平均付加モル数であり、10≦a+b≦300、2≦n≦50、及び0.75≦(a+b)/(a+b+n)≦0.99の関係を有する。) A solubilizer comprising an alkylene oxide derivative represented by the following formula (I):
HO- (EO) a- (AO) n- (EO) b-H (I)
(In the formula, EO is an oxyethylene group, AO is one or more oxyalkylene groups having 8 to 12 carbon atoms, and when AO is two or more, block addition or random addition The addition form of AO and EO is in the form of a block, a and b are the oxyethylene groups, n is the average number of moles of oxyalkylene groups, and 10 ≦ a + b ≦ 300, 2 ≦ n ≦ 50, and (It has a relationship of 0.75 ≦ (a + b) / (a + b + n) ≦ 0.99).
(B) 油性成分を0.001〜10質量%
含有し、成分(A)及び(B)の質量割合が(A)/(B)=0.1〜20である、可溶化組成物。 (A) 0.01 to 50% by mass of the alkylene oxide derivative according to claim 1 or 2
(B) 0.001 to 10% by mass of oil component
The solubilized composition which contains and the mass ratio of component (A) and (B) is (A) / (B) = 0.1-20.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010065488A JP5659524B2 (en) | 2010-03-23 | 2010-03-23 | A solubilizer comprising an alkylene oxide derivative and a solubilized composition containing the solubilizer. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010065488A JP5659524B2 (en) | 2010-03-23 | 2010-03-23 | A solubilizer comprising an alkylene oxide derivative and a solubilized composition containing the solubilizer. |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011195522A true JP2011195522A (en) | 2011-10-06 |
JP5659524B2 JP5659524B2 (en) | 2015-01-28 |
Family
ID=44874176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010065488A Active JP5659524B2 (en) | 2010-03-23 | 2010-03-23 | A solubilizer comprising an alkylene oxide derivative and a solubilized composition containing the solubilizer. |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5659524B2 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4612756B1 (en) * | 1969-09-22 | 1971-04-01 | ||
JPS5794018A (en) * | 1980-10-10 | 1982-06-11 | Oreal | Polyethylene glycol derivative and cosmetic and medicinal composition |
JP2001323165A (en) * | 2000-05-12 | 2001-11-20 | Asahi Denka Kogyo Kk | Asphalt emulsifier |
JP2009144070A (en) * | 2007-12-14 | 2009-07-02 | Kao Corp | Detergent composition for medical appliance |
JP2009143817A (en) * | 2007-12-11 | 2009-07-02 | Shiseido Co Ltd | Skin cleanser |
JP2009143816A (en) * | 2007-12-11 | 2009-07-02 | Shiseido Co Ltd | Skin care preparation |
-
2010
- 2010-03-23 JP JP2010065488A patent/JP5659524B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4612756B1 (en) * | 1969-09-22 | 1971-04-01 | ||
JPS5794018A (en) * | 1980-10-10 | 1982-06-11 | Oreal | Polyethylene glycol derivative and cosmetic and medicinal composition |
JP2001323165A (en) * | 2000-05-12 | 2001-11-20 | Asahi Denka Kogyo Kk | Asphalt emulsifier |
JP2009143817A (en) * | 2007-12-11 | 2009-07-02 | Shiseido Co Ltd | Skin cleanser |
JP2009143816A (en) * | 2007-12-11 | 2009-07-02 | Shiseido Co Ltd | Skin care preparation |
JP2009144070A (en) * | 2007-12-14 | 2009-07-02 | Kao Corp | Detergent composition for medical appliance |
Also Published As
Publication number | Publication date |
---|---|
JP5659524B2 (en) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4840829B2 (en) | Sunscreen cosmetics | |
EP2415459A1 (en) | External preparation for skin | |
JP5850394B2 (en) | Cosmetics | |
EP0882447B1 (en) | Soluble cosmetics | |
JP5662794B2 (en) | Water-in-oil emulsion composition | |
JP5659524B2 (en) | A solubilizer comprising an alkylene oxide derivative and a solubilized composition containing the solubilizer. | |
JP2014162724A (en) | Water-in-oil emulsion composition | |
JP2017081895A (en) | Oil-in-water type emulsion composition | |
JP6918548B2 (en) | Topical skin or cosmetics | |
JP2015166330A (en) | cosmetic | |
JP4073539B2 (en) | Cosmetics | |
JP2009091271A (en) | Solubilized cosmetic | |
JP2003342159A (en) | Cosmetic for preventing aging of skin | |
JP2003012492A (en) | Cosmetic | |
JP4991200B2 (en) | Solubilized cosmetics | |
JP5164179B2 (en) | Liquid cosmetic | |
JP2011207819A (en) | Sebum dissolving agent and skin care preparation for external use containing the same | |
JP2016150916A (en) | Sebum secretion inhibitor | |
JPH10298029A (en) | Solubilized cosmetic | |
JP2019131524A (en) | Cosmetic and skin external preparation | |
JP6324770B2 (en) | Solubilized cosmetics | |
JP2012254957A (en) | External skin preparation and production method thereof | |
JP2019131507A (en) | Skin external preparations or cosmetics | |
JP6209350B2 (en) | Acne control composition, external preparation for skin and cosmetics | |
JP2003206279A (en) | Pyridoxine derivative and skin care preparation and hair cosmetic containing the same pyridoxine derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130218 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140127 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140206 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141104 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141117 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5659524 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |